Skip to main content

Table 3 Example of a summary of findings table that includes a separate row to show the absolute events for disadvantaged groups

From: Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration

Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age

Patient or population: Children aged between 6 months and five years

Intervention: Vitamin A supplementation

Comparison: Placebo or usual care


Illustrative comparative risksa (95 % CI)

Relative effect  (95 % CI)

No. of Participants (studies)

Quality of the evidence (GRADE)


Diarrhoea-related mortality

Low risk population

RR 0.72; 95 % CI 0.57 to 0.91

90,951 (7 studies)

+++O moderate2

Total number of participants reflects number randomised to studies. The analysis combined cumulative risk and risk per/1000 years follow-up.

3 per 10001

2 per 1000 (2 to 3)

Follow-up: 48–104 weeks

Medium risk population

4 per 10001

3 per 1000 (2 to 4)

High risk population

9 per 10001

6 per 1000 (5 to 8)

  1. [94]